Policy Brief
⭐ 4.8
Pharmacovigilance for Pharmaceutical Firms: Ethical Considerations | 2025–2028 Trends
Abstract
This policy brief investigates “Pharmacovigilance for Pharmaceutical Firms: Ethical Considerations | 2025–2028 Trends” using a propensity score matching. Through a human-centered lens, the analysis integrates multi-source data to derive an actionable roadmap for researchers and practitioners.